Gene: GDA
Official Full Name: guanine deaminaseprovided by HGNC
Gene Summary: This gene encodes an enzyme responsible for the hydrolytic deamination of guanine. Studies in rat ortholog suggest this gene plays a role in microtubule assembly. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06076 | GDA Knockout cell line (HeLa) | Human | GDA | 1:3~1:6 | Negative | Online Inquiry |
KO06077 | GDA Knockout cell line (HCT 116) | Human | GDA | 1:2~1:4 | Negative | Online Inquiry |
KO06078 | GDA Knockout cell line (A549) | Human | GDA | 1:3~1:4 | Negative | Online Inquiry |
GDA Gene Knockout Cell Lines represent a cutting-edge tool for researchers aiming to explore gene function and pathophysiology in a cellular context. These cell lines are genetically engineered to lack specific GDA (Guanylate Deaminase) genes, allowing for the investigation of the biological roles these genes play in various cellular processes, including nucleotide metabolism and signal transduction. By constituting a precise knockout model, GDA gene knockout cell lines facilitate the study of diseases where GDA dysregulation is implicated, including certain cancers and metabolic disorders.
The primary mechanism of these cell lines involves the targeted deletion of GDA genes through CRISPR/Cas9 technology, ensuring that the resulting cells exhibit a complete absence of GDA protein expression. This provides a highly specific framework for dissecting the downstream effects of GDA absence, offering insights into alternative metabolic pathways and compensatory mechanisms that may become activated in its absence. Such functional assays can lead to a deeper understanding of cellular adaptation and resilience, vital for therapeutic innovation.
The scientific significance of GDA Gene Knockout Cell Lines extends to various applications in both basic research and clinical settings. They can be utilized for drug screening, genetic interaction studies, and the elucidation of signaling pathways that are activated upon GDA loss, making them invaluable for any laboratory focused on gene therapy development, cancer biology, or metabolic research.
Compared to other knockout models, which may suffer from incomplete gene loss or off-target effects, our GDA Gene Knockout Cell Lines stand out due to their high specificity and efficiency, ensuring that researchers receive robust and reproducible data. Additionally, these cell lines undergo rigorous quality control and validation to confirm the absence of unintended genetic modifications, thereby increasing their reliability for experimental use.
Investing in GDA Gene Knockout Cell Lines empowers researchers and clinicians to advance their studies with a state-of-the-art resource, ensuring that they remain at the forefront of innovation in gene functional analysis. As a company dedicated to providing high-quality biological products, we draw on extensive expertise in genetic engineering, assuring our customers that they are using the best tools available to achieve their research objectives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.